Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.

International journal of cancer - 15 Aug 2009

Peterson Neeraja B, Beeghly-Fadiel Alicia, Gao Yu-Tang, Long Jirong, Cai Qiuyin, Shu Xiao-ou, Zheng Wei

Abstract excerpt

Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors of matrix metalloproteinases which are involved in normal cellular processes and also in cancer development and progression. The purpose of this study was to evaluate polymorphisms in the TIMP-2 and TIMP-3 genes for their associations with breast cancer susceptibility and survival. Using data from the Shanghai Breast Cancer Study, 19 SNPs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Risk Factors

Share to Survival Rate

Share to Tissue Inhibitor of Metalloproteinase-2

Share to Tissue Inhibitor of Metalloproteinase-3

Source

Open in PubMed Open full text

Identifiers

PMID: 19431211
DOI: 10.1002/ijc.24405
PMCID: PMC2745995

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.PMID 19431211Read ↗

The contributions of the tissue inhibitor of metalloproteinase-1 genotypes to triple negative breast cancer riskSemantic proximity Read ↗

Biological and Clinical Significance of TIMPs Expression in Breast Cancer: a Bioinformatic AnalysisSemantic proximity Read ↗

Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.Semantic proximity Read ↗

Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.Semantic proximity Read ↗

No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.Semantic proximity Read ↗

Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.Semantic proximity Read ↗

Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.Semantic proximity Read ↗

Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.Semantic proximity Read ↗

TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.Semantic proximity Read ↗

No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis.Semantic proximity Read ↗

TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.Semantic proximity Read ↗

Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.